Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FP3CN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,618
Award facts
- Contract value 100% obligated
- $11,618.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,618.21 to supply Dupixent (dupilumab) 200 mg/1.14 mL syringes. This non-set-aside, firm fixed-price contract was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic immunosuppressant medication used to treat conditions such as atopic dermatitis, moderate-to-severe asthma, and other allergic inflammatory diseases, indicating this delivery order supports medical treatment needs within the Department of Defense healthcare system.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's competitive positioning in federal medical procurement reflects its extensive experience fulfilling federal pharmaceutical requirements across multiple therapeutic domains through open competition.
Quick answers
Who was awarded contract SPE2DB25FP3CN?
SPE2DB25FP3CN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FP3CN worth?
The government has obligated $11,618 on SPE2DB25FP3CN.
Is contract SPE2DB25FP3CN an order under another contract?
Yes. SPE2DB25FP3CN is a delivery order under SPE2DB22D3010, an indefinite delivery contract.
Was contract SPE2DB25FP3CN competed?
The extent of competition for SPE2DB25FP3CN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award